Expand Energy (EXE) Gains Following Impressive Q3 Performance
The share price of Expand Energy Corporation (NASDAQ:EXE) surged by 8.85% between October 31 and November 7, 2025, putting it among the Energy Stocks that Gained the Most This...
Insider Monkey Blog
Antero Resources (AR) – Among the Energy Stocks that Gained This Week
The share price of Antero Resources Corporation (NYSE:AR) surged by 8.86% between October 31 and November 7, 2025, putting it among the Energy Stocks that Gained the Most This...
Petrobras (PBR) Gains Following Strong Q3 Results
The share price of Petróleo Brasileiro S.A.
Here is Why Peabody Energy (BTU) Gained This Week
The share price of Peabody Energy Corporation (NYSE:BTU) surged by 10.83% between October 31 and November 7, 2025, putting it among the Energy Stocks that Gained the Most This...
Targa Resources (TRGP) Jumps Following Q3 Report
The share price of Targa Resources Corp.
EQT Gains Amid Rising Natural Gas Prices
EQT Corporation (NYSE:EQT) slid at the end of October after the company forecasted lower sales volumes for its fourth quarter, despite reporting better-than-expected profits in...
Core Natural Resources (CNR) Gained Over 13% This Week. Here is Why
The share price of Core Natural Resources, Inc.
Comstock Resources (CRK) Posts Impressive Performance in Q3
The share price of Comstock Resources, Inc.
Here is Why NGL Energy Partners (NGL) Skyrocketed This Week
The share price of NGL Energy Partners LP (NYSE:NGL) surged by 47.37% between October 31 and November 7, 2025, putting it among the Energy Stocks that Gained the Most This Week...
KeyBanc raises target on Arm Holdings plc (ARM) As Earnings Impress
Arm Holdings plc (NASDAQ:ARM) is among the most profitable semiconductor stocks to buy.
October Slip Overshadowed by United Microelectronics Corporation (NYSE:UMC) Yearly Gain
United Microelectronics Corporation (NYSE:UMC) is among the most profitable semiconductor stocks to buy.
The reason William Blair is standing firm on Monolithic Power Systems, Inc. (MPWR)
Monolithic Power Systems, Inc. (NASDAQ:MPWR) is among the most profitable semiconductor stocks to buy.
BNP Paribas Spots Major Upside in Analog Devices, Inc. (ADI) Ahead of Earnings
Analog Devices, Inc. (NASDAQ:ADI) is among the most profitable semiconductor stocks to buy.
Subtle Target Hike Shows JP Morgan Cautious Optimism On NXP Semiconductors N.V. (NXPI)
NXP Semiconductors N.V. (NASDAQ:NXPI) is among the most profitable semiconductor stocks to buy.
Bernstein Calls Turnaround At Texas Instruments Incorporated (TXN) Slow But Underway
Texas Instruments Incorporated (NASDAQ:TXN) is among the most profitable semiconductor stocks to buy.
Micron Technology, Inc. (MU) Gains Analyst Confidence On Solid Positioning
Micron Technology, Inc. (NASDAQ:MU) is among the most profitable semiconductor stocks to buy.
Institutional Buying Seen As Progressive Adds Broadcom Inc. (AVGO) Shares
Broadcom Inc. (NASDAQ:AVGO) is among the most profitable semiconductor stocks to buy.
Taiwan Semiconductor Manufacturing Company Limited (TSM) Posts Slowest Monthly Growth Since Early Last Year
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is among the most profitable semiconductor stocks to buy.
DuPont de Nemours (DD) Announces Q3 2025 Results; KeyBanc’s Yefremov Raises PT to $45
With net sales of $3.1 billion (up 7% YoY), DuPont de Nemours, Inc. (NYSE:DD) exceeded prior guidance and reinforced confidence in its post-spin-off trajectory.
SM Energy Company (SM) Reports Q3 2025 Results, Reports 26% YoY Production Growth
SM Energy Company (NYSE:SM) reported its third-quarter results on November 3, 2025.
H.C. Wainwright Reiterates “Buy” Rating on Denali Therapeutics (DNLI) With $32 PT Following Q3 Results
Fein’s bullish stance followed Denali Therapeutics Inc. (NASDAQ:DNLI)’s Q3 results.
Aurora Innovation (AUR) Closes Q3 2025 With $1.6 Billion in Liquidity
On October 28, 2025, Aurora Innovation, Inc. (NASDAQ:AUR) released its Q3 2025 results.
William Blair Reiterates “Buy” Rating on Viking Therapeutics (VKTX) Following New VK2735 Data
On November 6, 2025, Viking Therapeutics Inc.
Summit Therapeutics (SMMT) Reports Positive Results from the Phase III HARMONi Trial
On November 7, 2025, Summit Therapeutics Inc. (NASDAQ:SMMT) announced results from the Phase III HARMONi trial conducted in China.
Morgan Stanley Reaffirms “Buy” Rating on Ultragenyx Pharmaceutical (RARE) with $55 PT
The analyst’s bullish stance stemmed from Ultragenyx Pharmaceutical Inc.’s (NASDAQ:RARE) strong financial position, alongside its pivotal late-stage pipeline.
TD Cowen Reiterates “Buy” Rating on Vaxcyte (PCVX) With $50 PT
The analyst cited positive Phase II data from the company’s VAX-24 infant vaccine trials.
H.C. Wainwright Remains Bullish on Legend Biotech (LEGN), Cites Solid Growth Trajectory for CARVYKTI Therapy
Discussing the company’s robust growth trajectory for its CARVYKTI therapy, he pointed toward the therapy’s rising clinical potential.
Canaccord Genuity Remains Bullish on Strategy (MSTR), Cites Bitcoin Yield Strategy as Key Growth Driver
On November 3, 2025, Canaccord Genuity reiterated its “Buy” rating on Strategy Inc. (NASDAQ:MSTR), while raising its price target from $464 to $474.
Goldman Sachs Bullish on Amicus Therapeutics (FOLD) Following Q3 2025 Results
The revision follows the company’s performance in the third quarter, marked by the first positive GAAP net income and solid revenue execution.
RBC Capital Raises PT on Ocular Therapeutix (OCUL) to $24 Amid Solid Growth Trajectory
The revised target was attributed to the company’s strong execution in its SOL-1 wet age-related macular degeneration (wAMD) superiority study.
Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results
The revised target reflected the company’s robust performance in the third quarter of 2025.
Chime Financial (CHYM) Surpasses Its Guidance for Q3 2025, Reports 29% YoY Revenue Growth
This quarter surpassed the company’s guidance, helping Chime Financial, Inc.
RBC Capital Remains Bullish on Bread Financial Holdings (BFH) Amid Stable Outlook
On October 24, 2025, RBC Capital raised its price target on Bread Financial Holdings, Inc. (NYSE:BFH) from $64 to $70, maintaining a “Sector Perform” rating.
Jefferies Remains Bullish on Vale S.A. (VALE) Following Strong Q3 Results
On November 3, 2025, Jefferies raised its price target on Vale S.A. (NYSE:VALE) from $14 to $15, while maintaining a “Buy” rating.
Keefe, Bruyette & Woods Remains Bullish on Lincoln National Corporation (LNC) Following Q3 Results
Meanwhile, on October 30, 2025, Lincoln National Corporation (NYSE:LNC) released its Q3 results, marked by steady progress in strengthening its balance sheet, diversifying its...
Bank of America’s Akamine Remains Bearish on APA Corporation (APA), Cites High Operating Costs
On November 6, 2025, Bank of America Securities’ analyst Kalei Akamine maintained his “Sell” rating on APA Corporation (NASDAQ:APA) with a $20 price target.
UBS Maintains Neutral Stance on Bank OZK (OZK), Cites Mixed Credit Results
On October 28, 2025, UBS reduced its price target on Bank OZK (NASDAQ:OZK) from $57 to $50, while reiterating its “Neutral” rating.
The Western Union Company (WU) Introduces Its “Beyond” Strategy, Outlines Its Digital-First Expansion Plan
Western Union introduced its “Beyond” strategy at Investor Day in New York on November 6, 2025.
Roth Capital Remains Bullish on SM Energy (SM) Following Civitas Announcement
On November 4, 2025, Roth Capital reduced its price target on SM Energy Company (NYSE:SM) from $33 to $28, while reiterating its “Buy” rating.
Wolfe Research Sees Limited Upside for Civitas Resources, Inc. (CIVI) Following SM Energy Merger Announcement
On November 4, 2025, Wolfe Research downgraded Civitas Resources (NYSE:CIVI) from “Outperform” to “Peer Perform.” The investment firm’s revised rating reflects limited...
Morgan Reiterates Its Bullish Stance on Voya Financial (VOYA) Following Q3 2025 Results
This update followed Voya Financial, Inc.’s (NYSE:VOYA) Q3 2025 results announcement on November 4, 2025.
BofA Remains Neutral on Bristol-Myers Squibb Company (BMY), Expects Low Single-Digit Growth in the Long Term
On November 3, 2025, BofA raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) from $50 to $52, reiterating its “Neutral” rating.
Oppenheimer’s Horan Sees a Challenging Five-Year Outlook on Comcast Corporation (CMCSA)
On November 3, 2025, Oppenheimer’s Timothy Horan downgraded Comcast Corporation (NASDAQ:CMCSA) from “Outperform” to “Perform,” removing his $38 price target.
10 Stocks Beating the Market with Eye-Popping Gains
Ten stocks kicked off Monday’s trading leading the charge, in line with the overall market optimism, as investors cheered the looming end of a government shutdown, while taking...
Jefferies Remains Positive on Keurig Dr Pepper (KDP), Sees Investor Confidence Returning
Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the best dividend stocks to buy.
Bernstein Remains Bullish on Dollar General (DG), Maintains Buy Call
Dollar General Corporation (NYSE:DG) is one of the best dividend stocks to buy.
Morgan Stanley Sees Growth Ahead for Starbucks (SBUX), Keeps Buy Rating and $105 PT
Starbucks Corporation (NASDAQ:SBUX) is one of the best dividend stocks to buy.
Kroger (KR) Expands AI and Delivery Capabilities Through Instacart Partnership
The Kroger Co. (NYSE:KR) is one of the best dividend stocks to buy.
Hedge Fund Resource Center
